Details for Patent: 9,051,297
✉ Email this page to a colleague
Title: | Compositions and methods for treatment |
Abstract: | The present invention provides compounds and methods for the treatment of LFA-1 mediated diseases. In particular, LFA-1 antagonists are described herein and these antagonists are used in the treatment of LFA-1 mediated diseases. One aspect of the invention provides for diagnosis of an LFA-1 mediated disease and administration of a LFA-1 antagonist, after the patient is diagnosed with a LFA-1 mediated disease. In some embodiments, the LFA-1 mediated diseases treated are dry eye disorders. Also provided herein are methods for identifying compounds which are LFA-1 antagonists. |
Inventor(s): | Zhong; Min (Foster City, CA), Shen; Wang (San Mateo, CA), Oslob; Johan D. (Sunnyvale, CA), Barr; Kenneth (Boston, MA) |
Assignee: | SARcode Bioscience Inc. (Bisbane, CA) |
Filing Date: | May 12, 2014 |
Application Number: | 14/275,241 |
Claims: | 1. A compound having the following formula: ##STR00035## or a pharmaceutically acceptable salt thereof. 2. A pharmaceutical composition comprising an effective amount of a compound of claim 1 and a pharmaceutically acceptable vehicle. 3. The pharmaceutical composition of claim 2 wherein the pharmaceutically acceptable vehicle is suitable for ocular administration. 4. The pharmaceutical composition of claim 3 further comprising a preservative. |